Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Biochemical Pharmacology

• Publication date

  1989-05-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(89)90308-0PMID 2471534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• The striatum and cerebral cortex express different muscarinic receptor mRNAs

  1988cited by this paper
• A Putative M3 Muscarinic Cholinergic Receptor of High Molecular Weight Couples to Phosphoinositide Hydrolysis in Human SK‐N‐SH Neuroblastoma Cells

  1988cited by this paper
• Muscarinic receptor-mediated increase in cAMP levels in SK-N-SH human neuroblastoma cells.

  1988cited by this paper
• Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes

  1988cited by this paper
• AF-DX 116, a cardioselective muscarinic antagonist.

  1987cited by this paper
• Molecular properties of the muscarinic acetylcholine receptor.

  1987cited by this paper
• Distinct primary structures, ligand‐binding properties and tissue‐specific expression of four human muscarinic acetylcholine receptors.

  1987cited by this paper
• Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors.

  1987cited by this paper
• Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.

  1987cited by this paper
• A small multigene family encodes Gi signal-transduction proteins.

  1987cited by this paper
• Phosphatidylinositol turnover in neuroblastoma cells: Regulation by bradykinin, acetylcholine, but not μ- and δ-opioid receptors

  1986cited by this paper
• Phosphatidylinositol turnover in neuroblastoma cells: regulation by bradykinin, acetylcholine, but not mu- and delta-opioid receptors.

  1986cited by this paper
• Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.

  1986cited by this paper
• A human neuroblastoma cell line expresses mu and delta opioid receptor sites.

  1986cited by this paper
• Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation.

  1986cited by this paper
• Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.

  1986cited by this paper
• The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.

  1985cited by this paper
• Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.

  1984cited by this paper
• High-affinity [3H]pirenzepine binding to putative M1 muscarinic sites in the neuroblastoma x glioma hybrid cell line (NG 108-15).

  1984cited by this paper
• Bradykinin-induced rapid breakdown of phosphatidylinositol 4,5-bisphosphate in neuroblastoma X glioma hybrid NG108-15 cells.

  1984cited by this paper
• Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.

  1984cited by this paper
• The coupling of the neuronal muscarinic receptor to responses.

  1984cited by this paper
• Relationships between phosphoinositide and calcium responses to muscarinic agonists in astrocytoma cells.

  1984cited by this paper
• Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism.

  1984cited by this paper
• Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol.

  1983cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Pirenzepine distinguishes between different subclasses of muscarinic receptors

  1980cited by this paper
• Regulation of adenylate cyclase activity mediated by muscarinic acetylcholine receptors.

  1978cited by this paper
• Muscarinic response to acetylcholine in neuroblastoma times glioma hybrid cells.

  1975cited by this paper
• Muscarinic response to acetylcholine in neuroblastoma × glioma hybrid cells

  1975cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• The cellular model for Alzheimer's disease research: PC12 cells

  2023cites this paper
• Role of protein kinase C in central muscarinic inhibitory mechanisms regulating voiding in rats.

  2003cites this paper
• Muscarinic Acetylcholine Receptors

  2002cites this paper
• Muscarinic toxins from the green mamba.

  2000cites this paper
• Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.

  1999cites this paper
• Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion.

  1999cites this paper
• Differential muscarinic receptor binding of acetylcholinesterase inhibitors in rat brain, human brain and Chinese hamster ovary cells expressing human receptors.

  1997cites this paper
• Polygodial induces inositol phosphate turnover in human neuroblastoma SH-SY5Y cells.

  1996cites this paper
• Pharmacological evidence for the existence of different subtypes of muscarinic acetylcholine receptors for phosphoinositide hydrolysis in neonatal versus adult rat atria.

  1995cites this paper
• In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase.

  1995cites this paper
• Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists

  1995cites this paper
• Stimulation of Adenylyl Cyclase Mediated by Phospholipase C‐Linked M3 Muscarinic Receptor in Human Neuroblastoma SK‐N‐BE(2)C Cells

  1995cites this paper
• Muscarinic receptor selectivities of 3-Quinuclidinyl 8-xanthenecarboxylate (QNX) in rat brain.

  1994cites this paper
• Muscarinic receptor-mediated inhibition of mitogenesis via a protein kinase C-independent mechanism in M1-transfected A9 L cells.

  1994cites this paper
• Distinct induction of c-fos mRNA in NG108-15 cells transfected with muscarinic m1 and m3 receptors.

  1994cites this paper
• Muscarinic receptor-mediated increase in ζ-PKC expression in SK-N-SH human neuroblastoma cells

  1994cites this paper
• Interaction of organophosphorus compounds with muscarinic receptors in SH-SY5Y human neuroblastoma cells.

  1994cites this paper
• Synthesis of some dibenzodiazepinone derivatives as potent and m2-selective antimuscarinic compounds

  1994cites this paper
• Muscarinic receptor-mediated increase in zeta-PKC expression in SK-N-SH human neuroblastoma cells.

  1994cites this paper
• Differences in Ca2+ mobilization by muscarinic agonists in tracheal smooth muscle.

  1993cites this paper
• Muscarinic cholinergic receptors on murine lymphocyte subpopulations. Selective interactions with second messenger response system upon pharmacological stimulation.

  1993cites this paper
• M3 muscarinic acetylcholine receptor coupling to PLC in rat exorbital lacrimal acinar cells.

  1993cites this paper
• Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.

  1993cites this paper
• Muscarinic receptor regulation and 2nd messenger responses in rat neocortex cultures.

  1993cites this paper
• Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells.

  1992cites this paper
• Calcium Independence of Phosphoinositide Hydrolysis‐Induced Increase in Cyclic AMP Accumulation in SK‐N‐SH Human Neuroblastoma Cells

  1992cites this paper
• A novel m2-selective muscarinic antagonist: binding characteristics and autoradiographic distribution in rat brain.

  1992cites this paper
• Inositol Lipids and Signal Transduction in the Nervous System: An Update

  1992cites this paper
• Agents that stimulate phosphoinositide turnover also elevate cAMP in SK-N-SH human neuroblastoma cells.

  1992cites this paper
• Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart.

  1991cites this paper
• Biphasic dose-response curves to arecoline in rat atria-mediation by a single promiscuous receptor or two receptor subtypes?

  1991cites this paper
• Pharmacology of adenosine receptors of the rat isolated superior cervical ganglion

  1991cites this paper
• Muscarinic receptor subtype selectivity of novel heterocyclic QNB analogues.

  1991cites this paper
• Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.

  1991cites this paper
• Selection of Cholinergic Agents Which May Improve Memory

  1990cites this paper
• Second-messenger responses associated with stimulation of neuronal muscarinic receptors expressed by a human neuroblastoma SH-SY5Y.

  1990cites this paper
• Promiscuous or heterogeneous muscarinic receptors in rat atria? I. Schild analysis with simple competitive antagonists.

  1990cites this paper
• Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus

  1990cites this paper
• Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.

  1990cites this paper
• Pre- and postjunctional muscarinic receptors in canine bronchi.

  1990cites this paper
• Coupling mechanisms in airway smooth muscle.

  1990cites this paper
• Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.

  1990cites this paper
• Relationship between desensitization and sequestration of muscarinic cholinergic receptors in two neuronal cell lines.

  1989cites this paper
• An agonist that is selective for adenylate cyclase-coupled muscarinic receptors.

  1989cites this paper
• A Functionalized Congener Approach to Muscarinic Ligands

  1989cites this paper